Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check5 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics to the page's related topics.SummaryDifference0.1%

- Check12 days agoChange DetectedThe 'Schizophrenia' condition label and the 'MedlinePlus Genetics' related topics section were removed from the page. This reduces key contextual cues about the study's condition and related resources.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study details page.SummaryDifference0.1%

- Check27 days agoChange DetectedVersion v3.5.0 was added and the topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed (Revision: v3.4.3). The core study details on the page remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no trial content changes are indicated on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study page.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.